Monte carlo proton radiation therapy planning calculations

Transactions of the American Nuclear Society

Volumn 99, Issue , 2008, Pages 63-64

  Newhauser, Wayne D ^a   Zheng, Yuanshui ^a,b   Taddei, Phillip J ^a   Mirkovic, Dragan ^a   Fontenot, Jonas D ^c   Giebeler, Annelise ^c   Zhang, Rui ^c   Titt, Uwe ^a   Mohan, Radhe ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 62849092486     PISSN: 0003018X     EISSN: None     Source Type: Conference Proceeding    
DOI: None     Document Type: Conference Paper

References (7)

1. J. SIEBERS, Application of Monte Carlo to proton beam radiation therapy. In: Advanced Monte Carlo for Radiation Physics, Particle Transport Simulation, and Applications, ed A Kling, et al. (Lisbon: Springer) 1051-6(2000).
2. J. HÉRAULT, N. IBORRA, B. SERRANO AND P. CHAUVEL, Spread-out Bragg peak and monitor units calculation with the Monte Carlo Code MCNPX Med. Phys. 32 680-8 (2007).
3. P. J. TADDEI, J. D. FONTENOT, Y. ZHENG, D. MIRKOVIC, A. K. LEE, U. TITT, W. D. NEWHAUSER, "Reducing stray radiation dose to patients receiving passively scattered proton radiotherapy for prostate cancer," Phys. Med. Biol, 53, 2131 (2008).
4. U. TITT, N. SAHOO, X. DING, Y. ZHENG, W. NEWHAUSER, R. ZHU, J. POLF, M. GILLIN AND R. MOHAN, Assessment of the accuracy of an MCNPX-based Monte Carlo simulation model for predicting three-dimensional absorbed dose distributions, Phys. Med. Biol (in press).
5. D. B. PELOWITZ, ED., MCNPX™ User's Manual, Version 2.5.0, Los Alamos National Laboratory, Los Alamos, New Mexico (2005).
6. W. NEWHAUSER, J. FONTENOT, Y. ZHENG, J. POLF, U. TITT, N. KOCH, X. ZHANG, R. MOHAN, "Monte Carlo simulations for configuring and testing an analytical proton dose-calculation algorithm," Phys. Med. Biol., 52, 4569 (2007).
7. Y. ZHENG, W. NEWHAUSER, J. FONTENOT, P. TADDEI, R. MOHAN, "Monte Carlo study of neutron dose equivalent during passive scattering proton therapy," Phys. Med. Biol., 52, 4481 (2007).